Cloning, mapping, and characterization of activated leukocyte-cell adhesion molecule (ALCAM), a CD6 ligand
about
Structure of the human macrophage MARCO receptor and characterization of its bacteria-binding regionCD6 binds to pathogen-associated molecular patterns and protects from LPS-induced septic shockMolecular cloning, mapping to human chromosome 1 q21-q23, and cell binding characteristics of Spalpha, a new member of the scavenger receptor cysteine-rich (SRCR) family of proteinsCD6 regulates T-cell responses through activation-dependent recruitment of the positive regulator SLP-76Molecular model of the N-terminal receptor-binding domain of the human CD6 ligand ALCAMMEMD, a new cell adhesion molecule in metastasizing human melanoma cell lines, is identical to ALCAM (activated leukocyte cell adhesion molecule)Activated leukocyte cell adhesion molecule in breast cancer: prognostic indicatorCell Adhesion Molecules and Ubiquitination-Functions and SignificanceLesser-Known Molecules in Ovarian CarcinogenesisThe role of CD146 (Mel-CAM) in biology and pathologyCharacterization of the laminin binding domains of the Lutheran blood group glycoproteinMolecular basis for the homophilic activated leukocyte cell adhesion molecule (ALCAM)-ALCAM interactionMEMD/ALCAM: a potential marker for tumor invasion and nodal metastasis in esophageal squamous cell carcinomaThe membrane-proximal scavenger receptor cysteine-rich domain of CD6 contains the activated leukocyte cell adhesion molecule binding siteLocalization of Lutheran, a novel laminin receptor, in normal, knockout, and transgenic mice suggests an interaction with laminin alpha5 in vivoThe acquisition of novel N-glycosylation sites in conserved proteins during human evolutionGenome-wide association study of subclinical interstitial lung disease in MESA.Dynamic regulation of activated leukocyte cell adhesion molecule-mediated homotypic cell adhesion through the actin cytoskeleton.Cell Adhesion Molecule CD166/ALCAM Functions Within the Crypt to Orchestrate Murine Intestinal Stem Cell Homeostasis.Comparison of multiple single-nucleotide variant association tests in a meta-analysis of Genetic Analysis Workshop 19 family and unrelated data.Release of membrane-bound vesicles and inhibition of tumor cell adhesion by the peptide Neopetrosiamide A.A novel human recombinant single-chain antibody targeting CD166/ALCAM inhibits cancer cell invasion in vitro and in vivo tumour growth.Syntenin-1 and ezrin proteins link activated leukocyte cell adhesion molecule to the actin cytoskeletonExpression of SC1, a cell adhesion molecule, promotes the metastatic activities of the Gallus gallus lymphoblastoid cell line MDCC-MSB1 derived from Marek's disease.Human CD6 Down-Modulation following T-Cell Activation Compromises Lymphocyte Survival and Proliferative Responses.T cell activation and differentiation is modulated by a CD6 domain 1 antibody ItolizumabA genome-wide CRISPR screen identifies a restricted set of HIV host dependency factors.Characterization of the intestinal cancer stem cell marker CD166 in the human and mouse gastrointestinal tractThe accessory molecules CD5 and CD6 associate on the membrane of lymphoid T cells.Enhanced down-regulation of ALCAM/CD166 in African-American Breast Cancer.Enhanced immunoPET of ALCAM-positive colorectal carcinoma using site-specific ⁶⁴Cu-DOTA conjugation.CD6 as a therapeutic target in autoimmune diseases: successes and challenges.SHH propagates distal limb bud development by enhancing CYP26B1-mediated retinoic acid clearance via AER-FGF signalling.Prognostic value of CD166 expression in cancers of the digestive system: a systematic review and meta-analysis.JAM-A and ALCAM are therapeutic targets to inhibit diapedesis across the BBB of CD14+CD16+ monocytes in HIV-infected individuals.Relative percentage and zonal distribution of mesenchymal progenitor cells in human osteoarthritic and normal cartilage.Characterization of monocyte maturation/differentiation that facilitates their transmigration across the blood-brain barrier and infection by HIV: implications for NeuroAIDS.NF-kappaB P50/P65 hetero-dimer mediates differential regulation of CD166/ALCAM expression via interaction with micoRNA-9 after serum deprivation, providing evidence for a novel negative auto-regulatory loop.The miR-155-PU.1 axis acts on Pax5 to enable efficient terminal B cell differentiationAn engineered cysteine-modified diabody for imaging activated leukocyte cell adhesion molecule (ALCAM)-positive tumors.
P2860
Q24310733-69BD4A7D-467B-47F5-81BA-9B68F60EFC4EQ24315988-57695DDD-06E2-4EDF-B344-88F1C518AF1BQ24321971-9A667DBC-8593-4C6B-8714-23B6482F32E9Q24670421-8C007961-3588-452E-BC3C-E26D19B05033Q24675053-BB493075-B135-48DC-8C44-8DED26A72129Q24678256-22ABDC25-D75C-4283-9B10-4A74A975915CQ24806155-C5E3D8E5-6BFB-4208-B057-04A154D38560Q26771983-26019A67-B855-47C0-8C26-517D6002A861Q26784533-B95D156C-A1B1-4A2C-B5D9-44237415CDD9Q28142374-5DB79BB3-FE21-401B-AF88-E5EF113990A3Q28185304-7F0C99B6-E7F6-4FDC-AFA6-5BD1EC7DE7DFQ28212934-CF003EF6-35F5-4ED0-A8DE-CB5483052A36Q28262234-9E0FFBE7-6D11-4A13-B462-2142CAF165E0Q28288267-58BEB453-E9B9-4254-B068-E0AA1C9FB3D0Q28587935-73D731A8-E75E-413F-87D8-3A741322BC99Q28650549-D11B3DBA-FBAE-4625-8069-7E51FEE85E49Q30252379-7B1CFD6E-CAD3-44B1-85C6-40FADE6D6275Q30477536-1ED87BAF-1772-46A3-8367-FCC0ACA4CFC9Q30846910-E52383EE-7E0E-497B-98F1-E19B47F14788Q31149247-3D6EBA11-EDE8-4D0B-A586-3D0E8C077006Q33592938-098312FF-CBE4-42C5-BC86-5F4489F9BA2FQ33634142-E6E053C1-5CB9-400D-B6E0-8AA5AE3BB655Q33676712-47E69CA4-84AA-4FC4-86E3-847DE42ABD89Q33823820-4FAC8046-75D3-417C-B61F-DEE1EE475322Q33857839-262D8C73-5CA8-4B7E-B72A-849F767523AAQ33865748-CEB17C1E-502E-41DD-97CE-EEA7D719A51FQ33906477-E25DC3C8-8D14-4EFD-8804-C7CE8C4EC764Q34136852-5A00195A-DD48-4CEB-BD4F-8469AF219F81Q34163553-C4792C7D-720A-4ABA-B6E1-3785431AC517Q34309546-140B1BD9-165A-4664-9E4D-C93BA9319D9EQ34313174-473CAFEC-7CD4-40E2-9E82-E9569ACC552AQ34337963-BA78B386-7FD7-445A-A97A-88B59197E955Q34855838-141E1C40-F546-495D-884B-687D29B177E8Q34936453-91C83516-D3B2-47EB-B28A-201E86FA7B1AQ35005863-AC0D31BA-BBFA-4E5C-9E48-A765233365D7Q35093021-783CF679-6109-483D-90AF-76CF6CC8D8E5Q35105210-B3C8FB75-1196-48EE-B324-89D17C35C164Q35174757-154D6FDA-4FB2-4315-8015-BB7A17703A66Q35307418-4E478568-40F3-434D-B5FD-9748F899C477Q35583305-03C0E0D9-066E-4607-82C6-AD67404D8BD7
P2860
Cloning, mapping, and characterization of activated leukocyte-cell adhesion molecule (ALCAM), a CD6 ligand
description
1995 nî lūn-bûn
@nan
1995 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Cloning, mapping, and characte ...... molecule (ALCAM), a CD6 ligand
@ast
Cloning, mapping, and characte ...... molecule (ALCAM), a CD6 ligand
@en
Cloning, mapping, and characte ...... molecule (ALCAM), a CD6 ligand
@en-gb
Cloning, mapping, and characte ...... molecule (ALCAM), a CD6 ligand
@nl
type
label
Cloning, mapping, and characte ...... molecule (ALCAM), a CD6 ligand
@ast
Cloning, mapping, and characte ...... molecule (ALCAM), a CD6 ligand
@en
Cloning, mapping, and characte ...... molecule (ALCAM), a CD6 ligand
@en-gb
Cloning, mapping, and characte ...... molecule (ALCAM), a CD6 ligand
@nl
prefLabel
Cloning, mapping, and characte ...... molecule (ALCAM), a CD6 ligand
@ast
Cloning, mapping, and characte ...... molecule (ALCAM), a CD6 ligand
@en
Cloning, mapping, and characte ...... molecule (ALCAM), a CD6 ligand
@en-gb
Cloning, mapping, and characte ...... molecule (ALCAM), a CD6 ligand
@nl
P2093
P2860
P3181
P356
P1476
Cloning, mapping, and characte ...... molecule (ALCAM), a CD6 ligand
@en
P2093
A R Malacko
H Marquardt
J M Pesando
M Neubauer
P2860
P304
P3181
P356
10.1084/JEM.181.6.2213
P407
P577
1995-06-01T00:00:00Z